rs1229984 — ADH1B His48Arg

ADH1B variant encoding a ~100x faster alcohol dehydrogenase enzyme, causing rapid acetaldehyde accumulation, the "Asian flush" response, and strong protection against alcoholism — but elevated esophageal cancer risk in carriers who drink

See your personal result for ADH1B

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Alcohol Flush Gene — Why Some People Turn Red, and What It Means for Their Health

When ADH1B encodes the beta subunit of [alcohol dehydrogenase | The enzyme family responsible for the first step of alcohol metabolism in the liver, converting ethanol into acetaldehyde], the His48Arg variant (rs1229984, also called ADH1B*2 or Arg47His in older nomenclature) produces an enzyme that operates at a fundamentally different speed. Carriers of the His48 allele — the T allele on the genomic plus strand — have an ADH1B enzyme that metabolizes ethanol to acetaldehyde approximately 70- to 100-fold faster than the common Arg48 form.

The result is predictable: drink alcohol, and your body floods with [acetaldehyde | A reactive aldehyde that causes the characteristic flushing, nausea, and rapid heartbeat. Acetaldehyde is also classified as a Group 1 human carcinogen by the IARC] before your liver can clear it. This is the biological engine behind the "Asian flush" — common in East Asian populations where the His48 allele reaches frequencies of 70-80% or higher.

This is one of the strongest natural deterrents to heavy drinking in the human genome, and one of the most studied protective factors against alcohol use disorder ever identified.

The Mechanism

Alcohol metabolism proceeds in two steps. First, alcohol dehydrogenase (ADH1B) converts ethanol to acetaldehyde. Second, aldehyde dehydrogenase (ALDH2) converts acetaldehyde to harmless acetate. The ADH1B His48 variant supercharges the first step: the enzyme's Vmax for ethanol oxidation is increased roughly 100-fold, producing a surge of acetaldehyde faster than ALDH2 can clear it.

This acetaldehyde surge causes the classic physiological reactions — facial flushing, tachycardia, nausea, headache — within minutes of alcohol consumption. These aversive effects act as a natural deterrent: people who experience them strongly tend to drink less, and often stop drinking altogether. The biological mechanism is essentially the same as the pharmaceutical drug disulfiram (Antabuse), which blocks ALDH2 artificially to create the same acetaldehyde accumulation.

The Arg48 variant (C allele on plus strand), by contrast, produces an enzyme with much lower activity. Arg48/Arg48 carriers metabolize ethanol more slowly, accumulate less acute acetaldehyde, tolerate alcohol better, and face fewer biological barriers to heavy drinking.

The Evidence

Alcohol Use Disorder Protection: The protective effect of the His48 allele is among the most robustly documented findings in psychiatric genetics.

A meta-analysis of 78 studies encompassing 9,638 cases and 9,517 controls11 A meta-analysis of 78 studies encompassing 9,638 cases and 9,517 controls
Li D et al. Strong association of the ADH1B gene with alcohol dependence. Biological Psychiatry, 2011 found that the His48 allele provided greater than 2-fold protection against alcohol dependence in both dominant and allelic models, with the recessive (homozygous His48) model showing OR = 3.05 (P = 9×10⁻²³). The protective effect was strongest in East Asian populations.

In European and African-American populations — where the allele is rare — the protective effect remained genome-wide significant22 In European and African-American populations — where the allele is rare — the protective effect remained genome-wide significant
Bierut LJ et al. ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Molecular Psychiatry, 2012: OR = 0.34 (95% CI 0.24-0.48), P = 6.6×10⁻¹⁰.

A meta-analysis specifically of East Asian populations (31 studies, 5,409 cases and 8,182 controls)33 A meta-analysis specifically of East Asian populations (31 studies, 5,409 cases and 8,182 controls)
Zaso MJ et al. Meta-Analysis on Associations of Alcohol Metabolism Genes With Alcohol Use Disorder in East Asians. Alcohol and Alcoholism, 2019 confirmed the ADH1B*2 allele reduces alcohol use disorder risk with OR = 0.46 in the allelic model and OR = 0.22 in the recessive model, the latter representing a greater than 4-fold protection for His48 homozygotes.

Esophageal Cancer Risk: The same variant has a complex and clinically important relationship with cancer. The core paradox: the His48 allele causes rapid acetaldehyde accumulation, and acetaldehyde is a Group 1 human carcinogen. Carriers of the Arg48 allele (C on plus strand) drink more on average — and sustained alcohol exposure, even at lower acetaldehyde per session, accumulates carcinogenic damage over years.

A meta-analysis of 12 studies (4,220 cases, 8,946 controls)44 A meta-analysis of 12 studies (4,220 cases, 8,946 controls)
Zhang G et al. ADH1B Arg47His Polymorphism Is Associated with Esophageal Cancer Risk in High-Incidence Asian Population. PLoS One, 2010 found that the Arg/Arg genotype (CC on plus strand) was associated with OR = 3.86 (95% CI 2.96-5.03) for esophageal squamous cell carcinoma compared to His/His. With heavy alcohol drinking, the Arg/Arg genotype produced an approximately 20-fold increased risk (OR=20.69, 95% CI 5.09–84.13).

A more recent meta-analysis of 23 publications55 A more recent meta-analysis of 23 publications
Zhang B et al. Relationship between ESCC risk and alcohol-related ALDH2 and ADH1B polymorphisms. Cancer Medicine, 2023 confirmed ADH1B rs1229984 was associated with 2.50-fold (additive model) increased ESCC risk.

A large Taiwanese cohort (42,665 participants)66 A large Taiwanese cohort (42,665 participants)
Chang et al. Impacts of ADH1B rs1229984 and ALDH2 rs671 polymorphisms on risks of alcohol-related disorder and cancer. Cancer Medicine, 2023 reported that the CC genotype conferred OR = 4.10 for esophageal cancer (p<0.001), and that the combination of CC genotype plus ALDH2 deficiency (rs671) increased esophageal cancer risk 381% beyond individual effects alone.

Practical Actions

For His48 carriers (TC or TT genotype): If you experience flushing, nausea, or rapid heartbeat after drinking, your body is signaling real biological harm. These symptoms are not just discomfort — they reflect acetaldehyde accumulation. The deterrent works as a protective mechanism; people who override it and drink through the flush are at elevated risk for upper aerodigestive tract cancers including esophageal squamous cell carcinoma. The single most actionable implication of carrying the His48 allele is: if you flush, the biologically rational choice is to stop, not to push through.

For Arg48 homozygotes (CC genotype): You lack the natural biological deterrent that protects His48 carriers from heavy drinking. You may tolerate alcohol at higher doses without immediate aversive effects, which removes a protective signal that would otherwise limit consumption. If you drink heavily, your cancer risk from sustained alcohol exposure rises substantially — especially if you also carry the ALDH2 rs671 A allele.

The ALDH2 gene (rs671) is the other half of the equation: it encodes the enzyme that clears acetaldehyde. See the Interactions section for combined effects.

Interactions

The two most important variants in alcohol metabolism — ADH1B rs1229984 and ALDH2 rs671 — have documented synergistic effects on both alcohol use disorder and cancer risk.

The ADH1B His48 allele accelerates acetaldehyde production; the ALDH2 Lys487 allele (rs671 A allele) impairs its clearance. Carriers of both a His48 allele and a deficient ALDH2 allele get a double hit: faster production AND slower clearance of acetaldehyde. In East Asian populations, this combination is common and represents the population-level basis for the alcohol flush reaction in its most pronounced form.

For esophageal cancer, the combination of ADH1B Arg48 carriers (CC on plus strand) with impaired ALDH2 showed an OR of 4.81 in the Taiwan cohort — a 381% increased risk — representing additive and synergistic carcinogenic acetaldehyde exposure. Combined with alcohol and smoking77 Combined with alcohol and smoking
Cui R et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology, 2009, the risks multiply further.

ADH1B also interacts with rs2066702 (ADH1B*3, Arg370Cys), which provides independent protection against alcoholism primarily in African-ancestry populations, and with ADH1C variants (rs1693482, rs698) that influence the same metabolic pathway.

Genotype Interpretations

What each possible genotype means for this variant.

CC Standard Alcohol Metabolizer Normal

Common Arg48 genotype with standard ADH1B activity — you metabolize alcohol more slowly and lack the biological deterrent against heavy drinking

You have two copies of the Arg48 allele (C on the genomic plus strand), the ancestral form of ADH1B that produces an enzyme with standard activity — approximately 100-fold lower than the His48 variant. This is the most common genotype worldwide (roughly 70% of the global population) and the predominant form in people of European descent (over 95%). You are unlikely to experience the "flush response" and can typically consume moderate to large amounts of alcohol without immediate aversive effects.

Without the biological deterrent that His48 carriers experience, you rely entirely on behavioral choices to regulate alcohol consumption. This also means that if you drink heavily, your esophageal tissues are exposed to cumulative acetaldehyde without the natural limit that the flush provides.

CT Intermediate Alcohol Metabolizer Intermediate

One copy of the fast-metabolizing His48 allele — you likely experience mild alcohol flushing and have moderately reduced alcohol use disorder risk

Meta-analyses show the protective OR for alcohol dependence in heterozygotes is intermediate: OR ~0.46-0.49 (allelic/dominant model) compared to OR ~0.22 for homozygous His48 carriers. The effect is still substantial — roughly a 2-fold reduction in alcohol use disorder risk — but less complete than in TT individuals.

CT heterozygotes often experience mild flushing that is socially tolerable, and some drink regularly. For esophageal cancer risk, studies show His/Arg heterozygotes have an intermediate risk between His/His (lowest) and Arg/Arg (highest): OR = 1.62 (95% CI 1.49-1.76) compared to His/His in the meta-analysis of Asian populations, suggesting moderately elevated cancer risk relative to TT but substantially lower than CC.

TT Rapid Alcohol Metabolizer Fast

Your ADH1B enzyme converts alcohol to acetaldehyde ~100x faster than average — the biological basis of the "Asian flush"

The His48 homozygous genotype produces a superactive ADH1B enzyme with a Vmax for ethanol oxidation roughly 100-fold higher than the Arg48 wild-type. The resulting acetaldehyde surge outpaces the liver's capacity to clear it via ALDH2, producing systemic acetaldehyde toxicity within minutes of alcohol ingestion.

Meta-analyses show the protective effect against alcohol dependence is strongest in homozygotes: OR = 0.22 (recessive model) in East Asian populations, meaning His48/His48 individuals have a greater than 4-fold reduced risk of alcohol use disorder compared to Arg48/Arg48. In large cohort studies, fewer than 1 in 5 TT individuals report regular alcohol consumption.

The critical clinical nuance: if you override the flush response and continue drinking despite symptoms — common among social drinkers who take antihistamines or simply push through the discomfort — you accumulate acetaldehyde at high rates. Acetaldehyde is classified as a Group 1 human carcinogen by the International Agency for Research on Cancer, and sustained exposure damages the DNA of upper aerodigestive tract tissues including the esophagus, oral cavity, pharynx, and larynx.